Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review

Rui Bernardino, Rashid K. Sayyid, Ricardo Leão, Alexandre R. Zlotta, Theodorus vander Kwast, Laurence Klotz, Neil E. Fleshner

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)
7 Downloads (Pure)


The interest in broadening the application of active surveillance (AS) has been increasing, encompassing patients who may not strictly adhere to the conventional criteria for low-risk prostate cancer (PCa), particularly those diagnosed with small-volume Gleason grade group 2 disease. Nonetheless, accurately identifying individuals with low-intermediate risk PCa who can safely undergo AS without facing disease progression remains a challenge. This review aims to delve into the progression of this evolving trend specifically within this cohort of men, while also examining strategies aimed at minimizing irreversible disease advancement. Additionally, we address the criteria for patient selection, recommended followup schedules, and the indicators prompting intervention.

Original languageEnglish
JournalCanadian Urological Association Journal
Issue number4
Publication statusPublished - Apr 2024


Dive into the research topics of 'Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review'. Together they form a unique fingerprint.

Cite this